U.S. Pharmaceutical Desiccants Market Size, Share & Forecast 2026–2032

ID: MR-10949 | Published: November 2026
Download PDF Sample

Report Highlights

  • ✓Country: United States
  • ✓Market: Pharmaceutical Desiccants
  • ✓Market Size 2024: USD 285 million
  • ✓Market Size 2032: USD 425 million
  • ✓CAGR: 5.1%
  • ✓Base Year: 2025
  • ✓Forecast Period: 2026–2032
Market Growth Chart
Want Detailed Insights - Download Sample
Analyst Findings and Recommendations
FINDING 01
Qualification Data Beats Price: Qualification dossiers, not unit price, decide share in this market. Imported Chinese silica gel undercuts incumbent grades by roughly 30 percent, yet packagers rarely switch once Multisorb or Grace data is referenced in a validated container closure study.
FINDING 02
Commodity Assumption Breaks: Commonly assumed: the U.S. desiccants market is a mature commodity. In reality, oral GLP-1 formulations such as Rybelsus are highly moisture-sensitive, pushing blister and canister specifications toward tighter humidity limits that favor specialty molecular sieves over commodity silica.
ANALYST RECOMMENDATION

Analyst Recommendation — Dual-Source Before Tariffs: Packaging buyers must dual-source qualified desiccant grades from domestic converters by Q4 2026, because Section 301 tariffs on Chinese-origin silica and reshoring of solid-dose capacity will tighten available qualified supply. Write validated container closure data into every supplier contract.

Competitive Overview of U.S. Pharmaceutical Desiccants

The U.S. pharmaceutical desiccants market is moderately concentrated, with the top five suppliers holding an estimated 60 percent of qualified pharma-grade volume. Multisorb Technologies, a Buffalo-based specialist, anchors the segment through moisture and oxygen management for oral solid dose packaging, while Clariant and W. R. Grace supply silica and molecular sieve grades to large pharmaceutical packagers. International suppliers dominate upstream raw materials, but finished-dose qualification remains largely domestic.

Competitive advantage in this country turns on regulatory dossier support rather than unit price. Desiccant selection must be documented against container closure studies under FDA expectations, so suppliers that provide stability data packages and drug master file references win qualification. Equilibrium moisture performance at 25°C/60% RH and 40°C/75% RH determines acceptance, which favors vendors with tested adsorption isotherm data and domestic warehousing that supports just-in-time delivery to contract packagers in New Jersey, Indiana, and North Carolina.

Demand Drivers Shaping U.S. Pharmaceutical Desiccants

Reshoring of solid-dose manufacturing is the first driver. Tablet capacity added in North Carolina, Indiana, and Puerto Rico requires qualified desiccant supply near the point of fill, which benefits Multisorb Technologies and Clariant because both run U.S. converting and warehousing that shorten qualification lead times for contract packagers. Offshore suppliers cannot match that responsiveness, so incumbency at these sites is increasingly sticky.

Moisture-sensitive oral formulations form the second driver, and mail-order specialty pharmacy growth the third. Oral semaglutide and peptide tablets require tighter humidity control than legacy small molecules, pushing packagers toward molecular sieves from Honeywell UOP and Zeochem. Meanwhile, direct-to-patient dispensing favors sachets and humidity indicator cards, rewarding converters such as Multisorb that bundle formats with stability reporting across high-volume SKUs.

Competitive Restraints and Market Challenges

Price competition from imported silica gel is the sharpest restraint. Chinese-origin silica and molecular sieve grades undercut domestic list prices, and Section 301 tariffs have not eliminated the gap for commodity grades, which forces W. R. Grace and PQ Corporation to defend volume through bundled technical service rather than price alone. Margin compression is most acute in standard silica canisters sold to mid-size generic packagers.

Compliance cost and talent scarcity compound the pressure. Each new desiccant grade requires adsorption isotherm testing, container closure integrity validation, and OSHA crystalline silica exposure controls, costs that smaller converters struggle to carry. Analytical scientists with sorption and stability expertise are scarce in the Northeast and Midwest, and facilities in the Carolinas face a shortage of qualified QA technicians, slowing new-product qualification by several months.

Growth Opportunities for Market Players

Puerto Rico offers the most concentrated opportunity. Its pharmaceutical manufacturing cluster, anchored by large solid-dose and sterile operations, depends on imported desiccants with long lead times, so a domestic converter that stocks qualified grades on the island captures recurring demand. Multisorb and Clariant are positioned to serve it, but few mid-tier suppliers have built local inventory. Establishing a regional buffer stock within 12 months would secure long-term supply agreements.

Humidity indicator integration and serialization create a second opening. Packagers adopting DSCSA-compliant serialized blister lines want desiccant inserts combined with humidity indicator cards and printable traceability labels, a bundled product that existing commodity suppliers cannot provide. Players offering integrated insert-plus-indicator kits can command premiums, and early moves by Multisorb Technologies in this format reinforce its specialty position.

Market at a Glance

MetricValue
Market Size 2024USD 285 million
Market Size 2032USD 425 million
Growth Rate (CAGR)5.1%
Most Critical Decision FactorDocumented moisture performance and regulatory qualification data
Largest RegionMid-Atlantic and Southeast
Competitive StructureModerately concentrated; top five hold about 60% of qualified volume

Leading Market Participants

  • Multisorb Technologies
  • Clariant
  • W. R. Grace
  • Honeywell UOP
  • Zeochem
  • Evonik
  • Mitsubishi Gas Chemical
  • PQ Corporation
  • Cabot Corporation
  • Desiccare Inc.

Regulatory and Policy Environment

FDA oversight under 21 CFR Part 211, particularly Section 211.94 on drug product containers and closures, makes desiccant selection a regulated decision rather than a procurement choice. Packagers must document moisture performance under ICH Q1A(R2) stability protocols, and USP General Chapter 1207 on package integrity testing sets expectations that favor suppliers with validated data packages referenced in filings. Changes to a supplier's grade require prior approval, which locks in incumbents once qualified.

Trade and workplace rules shape cost competitiveness. Section 301 tariffs administered by the U.S. Trade Representative and classification rulings from U.S. Customs and Border Protection raise landed costs on Chinese-origin silica, while OSHA permissible exposure limits for respirable crystalline silica under 29 CFR 1910.1000 raise handling costs for domestic blenders. The Drug Supply Chain Security Act adds serialization requirements that reward converters with integrated labeling capability.

Competitive Outlook for U.S. Pharmaceutical Desiccants

Consolidation will continue through 2032 as mid-tier converters struggle with qualification costs. Expect acquisitions of regional packaging-component suppliers by Multisorb Technologies and by global chemical groups such as Clariant and Evonik, which seek domestic qualified capacity. Market concentration in premium grades will rise, with the top five share of qualified volume moving from roughly 60 percent toward 70 percent by 2032, while commodity silica remains fragmented across importers and distributors.

Specialty molecular sieves and integrated humidity-indicator systems will capture disproportionate growth. Honeywell UOP and Zeochem are best placed in sieve grades, while suppliers that couple desiccants with stability analytics and serialization will set the terms of supply. Price competition persists in standard canisters, so margin winners will be those that sell technical qualification support alongside product. Firms that delay domestic capacity investments beyond 2027 will lose share to integrated competitors.

Frequently Asked Questions

Multisorb Technologies leads in integrated moisture and oxygen management for oral solid dose packaging. Clariant and W. R. Grace hold strong positions in silica and molecular sieve supply to large packagers.
The top five suppliers hold an estimated 60 percent of qualified pharma-grade volume. Commodity silica remains fragmented across importers and distributors.
Documented moisture performance and container closure data referenced in regulatory filings drive qualification. Unit price matters mainly for standard grades used in non-critical packaging.
Yes, global groups such as Clariant, Evonik, and Honeywell UOP supply upstream materials and specialty grades. Chinese silica producers compete mainly on price in commodity segments.
Acquisitions of regional component suppliers by Multisorb Technologies and global chemical groups will reshape capacity. Watch for domestic inventory investments in Puerto Rico and the Carolinas.

Market Segmentation

By Product Type
  • Silica Gel
  • Molecular Sieves
  • Activated Clay
  • Calcium Oxide
  • Activated Alumina
By Packaging Format
  • Canisters
  • Sachets
  • Desiccant Inserts
  • Blister Inserts
  • Humidity Indicator Cards
By End User
  • Oral Solid Dose Manufacturers
  • Sterile Injectables Producers
  • Contract Packagers
  • Specialty Pharmacies
  • Biologics Fill-Finish Sites

Table of Contents

Chapter 01 Methodology and Scope
1.1 Research Methodology
1.2 Scope and Definitions
1.3 Data Sources
Chapter 02 Executive Summary
2.1 Report Highlights
2.2 Market Size and Forecast 2024-2032
Chapter 03 U.S. Pharmaceutical Desiccants - Market Analysis
3.1 Market Overview
3.2 Growth Drivers
3.3 Restraints
3.4 Opportunities
Chapter 04 By Product Type Insights
4.1 Silica Gel
4.2 Molecular Sieves
4.3 Activated Clay
4.4 Calcium Oxide
4.5 Others
Chapter 05 By Packaging Format Insights
5.1 Canisters
5.2 Sachets
5.3 Desiccant Inserts
5.4 Humidity Indicator Cards
5.5 Others
Chapter 06 By End User Insights
6.1 Oral Solid Dose Manufacturers
6.2 Contract Packagers
6.3 Specialty Pharmacies
6.4 Sterile Injectables Producers
6.5 Others
Chapter 07 Competitive Landscape
7.1 Market Players
7.2 Leading Market Participants
7.2.1 Multisorb Technologies
7.2.2 Clariant
7.2.3 W. R. Grace
7.2.4 Honeywell UOP
7.2.5 Zeochem
7.2.6 Evonik
7.2.7 Mitsubishi Gas Chemical
7.2.8 PQ Corporation
7.2.9 Cabot Corporation
7.2.10 Desiccare Inc.
7.3 Regulatory Environment
7.4 Outlook

Research Framework and Methodological Approach

Information
Procurement

Information
Analysis

Market Formulation
& Validation

Overview of Our Research Process

MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.

1. Data Acquisition Strategy

Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.

Secondary Research
  • Company annual reports & SEC filings
  • Industry association publications
  • Technical journals & white papers
  • Government databases (World Bank, OECD)
  • Paid commercial databases
Primary Research
  • KOL Interviews (CEOs, Marketing Heads)
  • Surveys with industry participants
  • Distributor & supplier discussions
  • End-user feedback loops
  • Questionnaires for gap analysis

Analytical Modeling and Insight Development

After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.

2. Market Estimation Techniques

MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.

Bottom-up Approach

Country Level Market Size
Regional Market Size
Global Market Size

Aggregating granular demand data from country level to derive global figures.

Top-down Approach

Parent Market Size
Target Market Share
Segmented Market Size

Breaking down the parent industry market to identify the target serviceable market.

Supply Chain Anchored Forecasting

MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.

Supply-Side Evaluation

Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.

3. Market Engineering & Validation

Market engineering involves the triangulation of data from multiple sources to minimize errors.

01 Data Mining

Extensive gathering of raw data.

02 Analysis

Statistical regression & trend analysis.

03 Validation

Cross-verification with experts.

04 Final Output

Publication of market study.

Client-Centric Research Delivery

MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.